Use of Baricitinib in Combination With Remdesivir and Steroid in COVID-19 Treatment: A Multicenter Retrospective Study

Introduction Hospitalized patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can develop severe complications. Baricitinib, a Janus kinase (JAK) JAK1/JAK2 inhibitor used to treat rheumatoid arthritis, has been proposed to prevent intracellular uptake of SARS-CoV-2 by...

Descripción completa

Detalles Bibliográficos
Autores principales: So, Jessica M, Umeh, Chukwuemeka, Noriega, Steven, Stratton, Erica, Aseri, Mahendra, Gupta, Rakesh C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786563/
https://www.ncbi.nlm.nih.gov/pubmed/35106192
http://dx.doi.org/10.7759/cureus.20620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786563/
https://www.ncbi.nlm.nih.gov/pubmed/35106192
http://dx.doi.org/10.7759/cureus.20620

Ejemplares similares